The CRL comes after the FDA accepted the NDA for review in October 2025 and set a Prescription Drug User Fee Act target ...
No Clinical Safety or Efficacy Concerns Currently Identified Agency Feedback Primarily Focused on CMC-Related RequestsCompany Plans Prompt ...
The cingulate cortex occupies a medial position in the cerebral hemispheres and extends from the frontal lobe (anterior cingulate cortex, ACC) through the midcingulate region (MCC) to the ...
By Siddhi Mahatole June 2 (Reuters) - Drug developer Cingulate said on Tuesday the U.S. Food and Drug Administration declined ...
The FDA rejected Cingulate Inc.'s ADHD medicine application over manufacturing issues. Cingulate holds nearly $30 million in ...
About Attention Deficit/Hyperactivity Disorder (ADHD)ADHD is a chronic neurobiological and developmental disorder that affects millions of children and often continues into adulthood. The condition is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results